Diabetes Care · 2001 · 160 citations · 17 references
MedicineEndocrinologyDiabetologyMetabolic PhysiologyMetabolic RegulationBody Composition ChangesCardiovascular DiseaseDiabetes MellitusMetabolic HealthMetabolic SyndromeCardiovascular Risk MarkersImpaired Glucose ToleranceMetabolic Syndrome AssociationsMetabolic Syndrome DyslipidemiaMetabolic Syndrome EpidemiologyProspective Cohort Data
OBJECTIVE: The metabolic syndrome is a loosely defined cluster of cardiovascular risk factors including low HDL cholesterol, hypertriglyceridemia, glucose intolerance, and hypertension. Evidence for inclusion of these features in the syndrome has mostly come from cross-sectional studies, and a few studies have examined how the various factors change together over time. RESEARCH DESIGN AND METHODS: We conducted a prospective population-based cohort study of 937 individuals aged 40-65 years who underwent oral glucose tolerance testing on two occasions at 4.5-year intervals. Changes in the components of the metabolic syndrome were analyzed by principal component analysis in the entire population and in a subgroup of 471 individuals who did not receive pharmaceutical therapy for hypertension and dyslipidemia. RESULTS: Principal component analysis identified three independent factors in men: a blood pressure factor (systolic and diastolic blood pressure and BMI), a glucose factor (fasting and 120-min postload glucose, BMI, waist-to-hip ratio [WHR], and fasting insulin level), and a lipid factor (triglycerides and HDL cholesterol, BMI, WHR, and fasting insulin level). In women, an additional factor was identified, which included BMI, WHR, fasting insulin, and triglycerides. Analysis of the contribution of these variables to the different subdimensions indicated that BMI was the central feature of the syndrome in both sexes. CONCLUSIONS: This analysis of change in the features of the metabolic syndrome over time provides evidence of the fundamental importance of obesity in the origin of this disorder.
17
Journal of AOAC INTERNATIONAL · 1975 · 19.9K citations
K. G. M. M. Alberti, Paul Zimmet · Diabetic Medicine · 1998 · 15.3K citations
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Steven M. Haffner, Rodolfo Valdéz, Helen P. Hazuda et al. · Diabetes · 1992 · 1.2K citations
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
Ele Ferrannini, S. M. Haffner, Braxton D. Mitchell et al. · Diabetologia · 1991 · 914 citations · Full text
Medicine, Endocrinology, Physiology +11
How Good a Marker Is Insulin Level for Insulin Resistance?
Markku Laakso · American Journal of Epidemiology · 1993 · 740 citations
Medicine, Cardiology, Endocrinology +13